About Resergene
Resergene is a Healthcare company based in Bengaluru (India) founded in 2014. Nutrition products and services in the healthcare sector in India. Its Indian entity Resergene Biosciences Private Limited reported revenue of ₹17.8 Lakh. Resergene offers products and services including Infalact and Accumaxe. Its focus areas include Nutraceuticals, Disease Management, Diabetes and Cancer Care and Clinical Nutrition.
Company details
Resergene Biosciences is noted for its provision of nutrition-focused products, where infant milk formula like Infalact is supplied alongside clinical nutrition options such as Accumaxe and Nutriserge for general, maternal, child, gut, immunity, diabetes, critical, cancer, renal, hepatic, and obesity care. These products are designed to address various health needs, with an emphasis on comprehensive support through scientifically formulated diets. The companys operations are based in Bangalore, India, ensuring accessibility for health-related applications.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Email••••••••
- Legal Name Resergene Biosciences Private Limited
- Date of Incorporation 02 Jun, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹17.8 Lakh
FY 2024 · +148% YoY
- Net Loss-₹81,133
FY 2024 · -5% margin
- EBITDA-₹81,085
FY 2024 · -5% margin
Associated legal entities of Resergene
Resergene operates through Resergene Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Resergene Biosciences Private Limited CIN U24100KA2014PTC074673 | Active | 02 Jun 2014 | Bangalore, Karnataka | ₹0.2 Cr | 2 | View details |
Products & Services of Resergene
Resergene offers a comprehensive portfolio of products and services, including Infalact and Accumaxe.
Infant milk formula is provided for nutritional support in early development stages.
Various formulations are offered for general health and specific conditions such as diabetes and cancer care.
Board of directors of Resergene Biosciences Private Limited (Resergene)
Resergene Biosciences Private Limited is the primary company behind Resergene. The board of Resergene Biosciences Private Limited currently have 2 directors; the longest-serving is Basavapatna Srinivas Venkataramiah, appointed in 2014. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Basavapatna Srinivas Venkataramiah DIN 06807841 | Director | 02 Jun 2014 | 12 yrs 4 mo | Resergene Biosciences Private Limited |
| Aswini Kumar Pujahari DIN 07332291 | Director | 31 Mar 2016 | 10 yrs 6 mo | Resergene Biosciences Private Limited |
Financials of Resergene
Figures of Resergene Biosciences Private Limited, the primary company behind Resergene, for FY 2024. Revenue was ₹17.8 Lakh (+148% year on year). Net loss was -₹81,133 (-5% margin). EBITDA was -₹81,085 (-5% margin). Revenue has grown at a compounded annual rate of +53% over three years and -4% over five years.
- ₹17.8 LakhRevenue · FY 2024 · +148% YoY
- -₹81,133Net loss · -5% margin
- -₹81,085EBITDA · -5% margin
- ₹5.6 LakhPaid-up capital
- +53%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Resergene Biosciences Private Limited are on its company page.
Detailed financial statements for Resergene
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Resergene
Resergene was founded in 2014.
Resergene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Resergene, Resergene Biosciences Private Limited, reported revenue of ₹17.8 Lakh for FY 2024, up 148% year on year.
Resergene Biosciences is noted for its provision of nutrition-focused products, where infant milk formula like Infalact is supplied alongside clinical nutrition options such as Accumaxe and Nutriserge for general, maternal, child, gut, immunity, diabetes, critical, cancer, renal, hepatic, and obesity care. These products are designed to address various health needs, with an emphasis on comprehensive support through scientifically formulated diets. The companys operations are based in Bangalore, India, ensuring accessibility for health-related applications.
Resergene offers Infalact and Accumaxe.
Resergene operates through Resergene Biosciences Private Limited.
The legal entities of Resergene currently have 2 directors, including Basavapatna Srinivas Venkataramiah, Aswini Kumar Pujahari.